COMMUNIQUÉS West-GlobeNewswire

Clinical Results for BeyondSpring’s Lead Asset, Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia, Demonstrated Superior Immune Profile Compared to Neulasta®
08/11/2018
Company to Present Latest Findings at 2018 Society for Immunotherapy of Cancer’s (SITC) Annual Meeting NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc . (NASDAQ: BYSI), a global biopharmaceutical company [...]
Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 Guidance
08/11/2018
CINCINNATI, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2018. Business Highlights: Completed [...]
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations
08/11/2018
Commercial team preparing for potential gene therapy launches BOSTON and LONDON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of [...]
THC Therapeutics Announces The US Patent office is granting a patent for their Cannabis Dryer
08/11/2018
The dHydronator ® is a Sanitizing Cannabis/Herb Sanitizing Dryer LAS VEGAS, Nov. 08, 2018 (GLOBE NEWSWIRE) -- THC Therapeutics Inc (OTC: MBLC) is a forward-thinking publicly traded Health and Wellness company in the [...]
resTORbio Co-Founder and Chief Medical Officer Joan Mannick, M.D., to Present on TORC1 Inhibition at The Gerontological Society of America 2018 Annual Scientific Meeting
08/11/2018
BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
ExCellThera announces clinical trial results using ECT-001 to be presented at ASH 2018 annual meeting
08/11/2018
MONTREAL, Nov. 08, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, today announced that results [...]
Resonant Inc. to Present at the Craig-Hallum 9th Annual Alpha Select Conference
08/11/2018
GOLETA, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, is scheduled to [...]
Active Biotech: New data from the Phase 2 LEGATO-HD study will be presented at HSG 2018
08/11/2018
PRESS RELEASE New data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference HSG 2018 Lund Sweden, November 8, 2018 - Active Biotech (NASDAQ STOCKHOLM: [...]
Auris Medical to Report Third Quarter 2018 Financial Results and Provide Business Update on Thursday, November 15, 2018
08/11/2018
Zug, Switzerland, November 08, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]
Pluristem Therapeutics Reports Fiscal 2019 First Quarter Results and Provides Corporate Update
08/11/2018
HAIFA, Israel, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today reported [...]
T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
08/11/2018
LEXINGTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Sorrento Therapeutics Closes Five-Year Term Loan Financing for Up to $150 Million
08/11/2018
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE), a clinical-stage immunotherapy biotech company, announces the closing of a debt financing for up to $150 million. The financing is [...]
Merus to Present at the Jefferies 2018 London Healthcare Conference
08/11/2018
UTRECHT, The Netherlands, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]
BioCryst to Present at Upcoming Investor Conferences
08/11/2018
RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the Jefferies London Healthcare Conference on Thursday, [...]
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio
08/11/2018
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio Upfront payment of US$15m Up to US$80m of development milestone payments Mid teen percentage profit share [...]
Antares Pharma to Present at the Jefferies 2018 Global Healthcare Conference
08/11/2018
EWING, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare [...]
Capricor Therapeutics to Present Corporate Overview and Poster at Action Duchenne International Conference
08/11/2018
Research Found Exosomes Increased Exercise Capabilities and Muscle Activity in a Mouse Model of Duchenne Muscular Dystrophy LOS ANGELES, Nov. 08, 2018 (GLOBE NEWSWIRE) -- During the Action Duchenne International [...]
Anavex Life Sciences Strengthens its Scientific Advisory Board with Distinguished Researcher for Clinical Treatment of Parkinson’s Disease Dementia (PDD)
08/11/2018
NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Chimerix Announces Third Quarter 2018 Financial Results
08/11/2018
- Conference Call at 8:30 a.m. ET Today - DURHAM, N.C., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, [...]

Pages